The approval of Yesintek and Yesintek I.V., biosimilars to Stelara, strengthens Biocon Biologics’ presence in North America and expands its immunology portfolio
​The approval of Yesintek and Yesintek I.V., biosimilars to Stelara, strengthens Biocon Biologics’ presence in North America and expands its immunology portfolio by Soban News (international And National News)
